2011-03-01 10:35 Ulf Skough har utsetts till ny VD för A+ Science Holding AB och tillträder den 1 mars med placering i Stockholm.
Tag: clinical trial
Pressmeddelanden
2009-02-05 10:20 Results of the ALLAY study, published in Circulation, shows that Aliskiren is as effective as Losartan in reducing LV mass. The follow-up (after 36 weeks) also showed that Aliskiren proved equally effective in lowering blood pressure. Aliskiren is the first orally active direct renin inhibitor.
2009-01-27 11:00 The CAFE-LLA* study prospectively examined the impact of Atorvastatin* (10 mg once daily) on central aortic pressures in hypertensive patients. The therapy did not influence central aortic pressure or hemodynamics in these patients. In other words the favourable effects of Statins on cardiovascular outcomes in hypertensive patients are independent of large-artery function and central pressures.
Visa alla 4 pressmeddelanden »
Nyheter
2010-09-13 18:01 Swedish Medtech makes A+ Science network partner
2010-02-20 11:29 The Lancet, published february 18, contained an article with further findings from the ACCOMPLISH trial.
2009-12-14 14:30 Biotech Sweden, one of the Nordic countries most read news media, elects an editorial council. The council aims to act as advisors and gather information about everything that affects the life science industry. Among the elected is A+ Science CEO, Agneta Franksson.
Kontaktpersoner
Ulf Skough har tidigare arbetat på ledande positioner nationellt och internationellt på stora läkemedelsföretag. Innan anställningen på A+ Science var Skough landschef för Baltikum på ScheringPlough. Han var dessförinnan affärsområdeschef och internationell marknadsdirektör på Pharmacia.